Promethazine HCl: Histamine Antagonist for Inflammation Rese
Promethazine HCl: Histamine Antagonist for Inflammation Research
Executive Summary: Promethazine HCl (SKU B4784) is a phenothiazine derivative with a molecular weight of 320.88, primarily acting as a histamine H1 receptor antagonist (product_spec). It is highly soluble in DMSO (≥14.2 mg/mL), water (≥17.57 mg/mL), and ethanol (≥5.38 mg/mL, ultrasonic), enabling versatile assay integration (product_spec). Recent studies demonstrate that phenothiazines, including promethazine hydrochloride, enhance macrophage antibacterial activity by inducing reactive oxygen species (ROS) and autophagy (Qiu et al., 2025). Promethazine HCl is thus widely utilized in research on histaminergic signaling pathways, immunology, and neuroscience receptor modulation (review). The compound should be stored desiccated at -20°C for optimal stability and purity (≥98%) (product_spec).
Biological Rationale
Promethazine hydrochloride is a synthetic phenothiazine derivative widely used in laboratory settings for the investigation of histamine-mediated cellular responses and immune regulation (protocol_article). As a histamine H1 receptor antagonist, it effectively blocks histaminergic signaling in both central and peripheral tissues, providing a controlled platform for dissecting allergic, inflammatory, and neurological pathways (product_spec). Its structural similarity to other phenothiazines allows comparative studies on G protein-coupled receptor (GPCR) signaling and host-pathogen interactions (Qiu et al., 2025).
Mechanism of Action of Promethazine HCl
Promethazine HCl acts as a competitive antagonist at histamine H1 receptors, thereby inhibiting histamine-induced vascular permeability, smooth muscle contraction, and neurotransmitter release (product_spec). In macrophages, promethazine hydrochloride has been shown to increase lysosomal activity and induce autophagy, leading to enhanced degradation of intracellular pathogens (Qiu et al., 2025). Additionally, treatment with promethazine results in the accumulation of reactive oxygen species (ROS), a critical mechanism in host-directed antibacterial defense. The combined effects on ROS and autophagy are abrogated by specific inhibitors, confirming a causal relationship (Qiu et al., 2025).
Evidence & Benchmarks
- Promethazine HCl increases ROS production in macrophages, correlating with enhanced antibacterial activity (Qiu et al., 2025, peer_reviewed_article).
- Autophagy induction by phenothiazines is necessary for the observed antibacterial effects; inhibition of autophagy or ROS abolishes these benefits (Qiu et al., 2025, peer_reviewed_article).
- Promethazine HCl demonstrates high solubility in DMSO (≥14.2 mg/mL), water (≥17.57 mg/mL), and ethanol (≥5.38 mg/mL, ultrasonic) for assay formulation (product_spec).
- Purity is typically ≥98% under recommended storage conditions (desiccated, -20°C), supporting reproducibility in sensitive cell assays (product_spec).
- Promethazine hydrochloride is supplied as either a 10 mM DMSO solution or as a solid for customized protocol requirements (product_spec).
This article updates and extends "Promethazine HCl in Immunology: Protocols, Assays & Insights" by providing direct, recent evidence for ROS and autophagy mechanisms in macrophage antibacterial activity. For protocol and troubleshooting details, refer to the scenario-driven guide "Promethazine HCl (SKU B4784): Reliable Solutions for Cell Assays", which focuses on assay design and reproducibility. The mechanistic overview also complements "Promethazine HCl in Translational Research" by mapping experimental findings onto translational strategies.
Applications, Limits & Misconceptions
Promethazine HCl is valuable for:
- Dissecting histaminergic signaling pathways in immunology and neuroscience (review).
- Studying GPCR/G protein signaling with phenothiazine scaffolds (protocol_article).
- Exploring host-directed antibacterial strategies via ROS and autophagy induction (Qiu et al., 2025).
- Optimizing cell viability and inflammation research protocols in vitro (assay_guide).
Common Pitfalls or Misconceptions
- Promethazine HCl is not a direct-acting antibiotic; its antibacterial effects rely on host cell mechanisms (Qiu et al., 2025).
- It is not intended for diagnostic or therapeutic use in humans or animals (product_spec).
- Overconcentration may lead to cytotoxicity; titration is essential for each assay (assay_guide).
- Its effects on non-macrophage cell types and in vivo pharmacokinetics may differ from in vitro findings (workflow_recommendation).
- Storage outside the recommended conditions can reduce potency and purity (product_spec).
Workflow Integration & Parameters
Protocol Parameters
- cell viability assay | 1–20 μM | in vitro | Standard titration range to minimize cytotoxicity and optimize histamine receptor blockade | workflow_recommendation
- macrophage ROS/autophagy induction | 10 μM, 24 h incubation | in vitro, murine macrophages | Dosage/timepoint validated for robust ROS/autophagy without overt toxicity | peer_reviewed_article (Qiu et al., 2025)
- solubility in DMSO | ≥14.2 mg/mL | solution prep | Enables high-concentration stock solutions for flexible dosing | product_spec (product_spec)
- storage | desiccated, -20°C | all formats | Maintains ≥98% purity and activity | product_spec (product_spec)
- vehicle control | 0.1% DMSO | negative control | Minimizes solvent-induced assay artifacts | workflow_recommendation
Conclusion & Outlook
Promethazine HCl is a rigorously characterized tool for dissecting histaminergic, immune, and inflammatory processes in preclinical research. Its unique profile as a host-directed, non-antibiotic modulator of macrophage antibacterial activity—mediated by ROS and autophagy—positions it as a model compound for addressing antimicrobial resistance and intracellular pathogen challenges (Qiu et al., 2025). APExBIO provides Promethazine HCl with industry-standard purity and documentation, supporting reproducibility in cell-based assays (product_spec). Ongoing research will further clarify its translational potential in immune and neuroinflammation models, but current evidence supports its robust use in GPCR signaling and host-pathogen studies. For detailed experimental design and troubleshooting, refer to scenario-driven resources and protocol compendia linked above.